Live corpus
Active intelligence prompt Pediatric cancer: surface high-value therapeutic signals across pediatric oncology literature.
PEDIATRIC CANCER RESEARCH INTELLIGENCE

Finding therapies hidden in 40,199 pediatric cancer papers.

Neurocompute scores pediatric oncology literature, surfaces overlooked therapeutic signals, and turns fragmented childhood cancer research into a living discovery terminal.

40,199 Papers indexed
1,440 Papers AI scored
40,199 Ranked papers
100.0% Coverage
PATIENT-FRIENDLY SUMMARY

CHIP-AML22: a complex clinical trial in de novo pediatric AML patients, including a gemtuzumab ozogamicin randomization and targeted therapy with quizartinib in eligible subgroups, within the NOPHO-DB-SHIP consortium.

For education only—not personal medical advice.

LIVE PEDIATRIC ONCOLOGY INTELLIGENCE
↑ Therapeutic signals emerging ↑ New pediatric cancer papers ingested ↑ Cross-paper convergence detected ↑ Human relevance scores updating ↑ Overlooked treatment paths surfacing
TOP PEDIATRIC CANCER SIGNALS

Ranked Discovery Journal Articles

View all discoveries →
PEDIATRIC CANCER RESEARCH TERMINAL

All ranked pediatric cancer papers

40199 results
C
Health risk assessment of indoor formaldehyde exposure across Chinese residences: Effects of building material grades.
PMID 40056527 Published: 2025-03-04 Ingested: 2026-08-02 12:03 AM Journal of hazardous materials
AI -
Standard 56.2
Final -
AI Summary

This pediatric cancer paper has not been AI summarized yet.

Why It Matters

Deterministic evidence score: 56.2/100. Study design: 55.0; human relevance: 85.0; therapeutic relevance: 16.0; sample size: 20.0; recency: 90.0; abstract quality: 85.0.

C
Outcomes of Oncologic Total Humeral Reconstruction.
PMID 40037861 Published: 2025-03-01 Ingested: 2026-08-02 12:04 AM Anticancer research
AI -
Standard 56.2
Final -
AI Summary

This pediatric cancer paper has not been AI summarized yet.

Why It Matters

Deterministic evidence score: 56.2/100. Study design: 55.0; human relevance: 85.0; therapeutic relevance: 16.0; sample size: 20.0; recency: 90.0; abstract quality: 85.0.

C
Mission 2030: Toward universal hepatitis B immunization.
PMID 40023933 Published: 2025-03-02 Ingested: 2026-08-02 12:03 AM Human vaccines & immunotherapeutics
AI -
Standard 56.2
Final -
AI Summary

This pediatric cancer paper has not been AI summarized yet.

Why It Matters

Deterministic evidence score: 56.2/100. Study design: 55.0; human relevance: 85.0; therapeutic relevance: 26.0; sample size: 20.0; recency: 90.0; abstract quality: 65.0.

C
Cancer- and non-cancer risk prioritization of regulated mycotoxins in Taiwan: Insights from the 2018-2022 official Mycotoxin monitoring survey.
PMID 39993462 Published: 2025-02-22 Ingested: 2026-08-02 12:03 AM Food and chemical toxicology : an international journal published for the British Industrial Biological Research Association
AI -
Standard 56.2
Final -
AI Summary

This pediatric cancer paper has not been AI summarized yet.

Why It Matters

Deterministic evidence score: 56.2/100. Study design: 55.0; human relevance: 85.0; therapeutic relevance: 16.0; sample size: 20.0; recency: 90.0; abstract quality: 85.0.

C
Advancing Pediatric Surgery with Indocyanine Green: Nonhepatobiliary Applications and Outcomes.
PMID 39968267 Published: 2025-01-07 Ingested: 2026-08-02 12:03 AM Journal of Indian Association of Pediatric Surgeons
AI -
Standard 56.2
Final -
AI Summary

This pediatric cancer paper has not been AI summarized yet.

Why It Matters

Deterministic evidence score: 56.2/100. Study design: 55.0; human relevance: 85.0; therapeutic relevance: 16.0; sample size: 20.0; recency: 90.0; abstract quality: 85.0.

C
AI -
Standard 56.2
Final -
AI Summary

This pediatric cancer paper has not been AI summarized yet.

Why It Matters

Deterministic evidence score: 56.2/100. Study design: 45.0; human relevance: 85.0; therapeutic relevance: 16.0; sample size: 50.0; recency: 90.0; abstract quality: 85.0.

C
Constitutional Mismatch Repair Deficiency: Scoping Review of a Cancer-Predisposition Syndrome With Distinctive Cutaneous Findings.
PMID 39910726 Published: 2025-02-05 Ingested: 2026-08-02 12:03 AM Pediatric dermatology
AI -
Standard 56.2
Final -
AI Summary

This pediatric cancer paper has not been AI summarized yet.

Why It Matters

Deterministic evidence score: 56.2/100. Study design: 55.0; human relevance: 85.0; therapeutic relevance: 16.0; sample size: 20.0; recency: 90.0; abstract quality: 85.0.

C
Infants' Exposure to Toxic Trace Elements in Teethers.
PMID 39873894 Published: 2025-01-28 Ingested: 2026-08-02 12:03 AM Biological trace element research
AI -
Standard 56.2
Final -
AI Summary

This pediatric cancer paper has not been AI summarized yet.

Why It Matters

Deterministic evidence score: 56.2/100. Study design: 55.0; human relevance: 85.0; therapeutic relevance: 16.0; sample size: 20.0; recency: 90.0; abstract quality: 85.0.

Previous
Page 2478 of 3350
Next
Before you continue

AI-assisted research information

Neurocompute uses AI to summarize scientific papers, interpret research signals, and suggest relevant reference links. AI-generated content can be incomplete, misleading, or wrong, and generated links may be irrelevant or unavailable.

Our reviewed outputs have performed strongly to date, but past accuracy is not a guarantee. Verify summaries, scores, claims, and links against the original publication before relying on them.

This platform is for research and education only. It does not provide medical advice, diagnosis, treatment recommendations, or clinical guidance.

Pediatric cancer research intelligence graphic
PEDIATRIC CANCER VISUAL SYSTEM

Open the Research Intelligence Map

Explore the active pediatric oncology analysis view.

Expand Intelligence View →
Full Pediatric cancer research intelligence graphic